Alpha Cognition Inc. - ACOG Earnings growth forecast for next year
Alpha Cognition collaborates with specialized medical centers to study cognitive recovery. The trend of the forward net income indicator confirms the volatility of expectations, where 53.20 determines this parameter level. Strict FDA control and the patent protection of Alpha-1062 create significant barriers to entry. However, the bet on a single Alzheimer's drug increases the risks of single-product dependence during commercialization.
Analytical breakdowns for Alpha Cognition Inc. (ACOG)
- stock quotes and analyst forecast:
- issuer market value details:
- book capitalization indicators:
- company liabilities and liquidity data:
Debt to Equity Alpha Cognition|ACOG - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Alpha Cognition Inc|ACOG - Company Total Debt Obligations|Debt to Book Value Alpha Cognition|ACOG - Amount of Long-Term Liabilities|Company Short-Term Debts Alpha Cognition|Quick Liquidity alphacognition.com
- net income and valuation ratios data:
ACOG - Company Net Income|Expected Profit Alpha Cognition|ACOG - Price to Earnings Multiple|Forward P/E Multiple Alpha Cognition Inc|ACOG - PEG Multiple|EV/EBITDA Multiple Alpha Cognition|ACOG - Operating profit before deduction of amortization|Earnings per share for the last twelve months Alpha Cognition|ACOG - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth alphacognition.com|ACOG - Net earnings per share change in current year|Net earnings per share growth forecast for next year Alpha Cognition
Initial company analysis:Alpha Cognition
The fundamental valuation of shares is based on the business's ability to generate future cash flows. This indicator reflects the daily price action of the projected growth in net earnings per share, allowing for the tracking of changes in expert consensus estimates. By analyzing expectations for the company's EPS growth next year, an investor can gauge market optimism regarding the success of dementia drugs. For Alpha Cognition (ACOG), this metric depends on regulatory approvals rather than macroeconomic cycles.
Direct competitors
Expected earnings per share growth for next year BIIB|NBIX: Expected earnings per share trend next year|Earnings growth forecast for next year RGC|Expected earnings per share growth for next year axsome.com AXSM|Net earnings per share growth forecast for next year ACADIA Pharmaceuticals Inc. ACAD|Xenon Pharmaceuticals Inc. (XENE) - Expected net earnings per share growth next year|Viking Pharma - Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Supernus Corp (SUPN)|Catalyst Pharmaceuticals (CPRX) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year DNLI|HRMY (Harmony Biosciences Holdings, Inc.) - Earnings growth forecast for next year|Biohaven Ltd (BHVN) - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year AMLX (Amylyx)|Projected earnings per share increase next year TRVI|Earnings growth forecast for next year PRAX (Praxis Precision Medicines)|Consensus forecast of earnings per share growth for next year anavex.com (AVXL)|CBLL - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Prothena Corporation plc|alector.com (ALEC) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year ANNX|OMER (Omeros Corp) - Earnings growth forecast for next year|Earnings growth forecast for next year neurogene.com|Earnings growth forecast for next year ACIU|Expected earnings per share growth for next year Voyager Therapeutics Inc VYGR|Net earnings per share growth forecast for next year Neumora Therapeutics Inc NMRA|Scilex Holding Company, Inc. (SCLX) - Expected net earnings per share growth next year|Tevogen Bio Holdings - Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Cognition Therapeutics Inc. (CGTX)|Inhibikase Therapeutics, Inc. (IKT) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year SAVA|ASRT (Assertio Holdings) - Earnings growth forecast for next year|Expected net earnings per share growth next year Coya COYA|Expected earnings per share growth for next year VTGN (Vistagen Therapeutics)|Earnings growth forecast for next year ovidrx.com (OVID)|Net earnings per share growth forecast for next year Acumen Pharmaceuticals, Inc. ABOS|Expected earnings per share trend next year CRVO|ATHE - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Clene Inc.|PEPG: Earnings growth forecast for next year|Jupiter Neurosciences, Inc. (JUNS) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Relmada Therapeutics, Inc.|Net earnings per share growth forecast for next year ANVS|Net earnings per share growth forecast for next year Grace Therapeutics, Inc. (GRCE)|AIFF: Net earnings per share change forecast for next year|Earnings growth forecast for next year KLTO (Klotho Neurosciences)|Expected earnings per share trend next year NRSN|Reviva Pharmaceuticals Holdings, Inc. - Earnings growth forecast for next year|MTVA - Earnings growth forecast for next year|NRXS (NeurAxis, Inc) - Expected earnings per share growth for next year|Helius Medical Technologies - Expected earnings per share trend next year|PASG (Passage Bio Inc.) - Earnings growth forecast for next year|Expected earnings per share growth for next year Neuphoria (NEUP)|Net earnings per share growth forecast for next year Minerva Neurosciences, Inc. (NERV)|ATHA - Expected net earnings per share growth next year|Earnings growth forecast for next year ADXN (Addex Therapeutics, Ltd.)|Net earnings per one share growth forecast for next year Alzamend Neuro Inc.|CYCN - Net earnings per share growth forecast for next year|PTIX (Protagenic Therapeutics) - Projected earnings per share growth rate for next year|KTTA: Earnings growth forecast for next year|CRGT - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year ATXI|BCLI (BrainStorm Cell Therapeutics Inc.) - Projected earnings per share increase next year|Earnings growth forecast for next year CARA|Consensus forecast of earnings per share growth for next year chromocell.com|Net earnings per share growth forecast for next year Eliem Therapeutics Inc. ELYM|Intra-Cellular Therapies Inc. (ITCI) - Expected net earnings per share growth next year|LBPH - Net earnings per share growth forecast for next year|MRNS (Marinus Pharma) - Projected earnings per share growth rate for next year|NKGN: Earnings growth forecast for next year|neurobopharma.com (NRBO) - Earnings growth forecast for next year|SAGE (Sage Therapeutics) - Earnings growth forecast for next year|Expected earnings per share growth for next year Synaptogenix Inc. (SNPX)|Net earnings per share growth forecast for next year Trevena, Inc (TRVN)|VIGL - Expected net earnings per share growth next year|Earnings growth forecast for next year WENA (Anew Medical)|Net earnings per one share growth forecast for next year cerevel.com
